Article
Nutritional and metabolic management for cystic fibrosis in a post-cystic fibrosis transmembrane conductance modulator era.
Current opinion in pulmonary medicine - 1 Nov 2022
Wilschanski Michael, Peckham Daniel
Abstract excerpt
PURPOSE OF REVIEW: The introduction of highly effective cystic fibrosis transmembrane conductance regulator modulators has resulted in a paradigm shift towards treating underlying cause of cystic fibrosis (CF) rather than the ensuing complications. In this review, we will describe the impact of these small molecules on growth, nutrition, and metabolic status in people with CF (pwCF). RECENT FINDING: Results of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
